Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Constellation Pharmaceuticals Inc (CNST)

Constellation Pharmaceuticals Inc (CNST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,628,631
  • Shares Outstanding, K 47,915
  • Annual Sales, $ 0 K
  • Annual Income, $ -126,360 K
  • 60-Month Beta 2.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.32
Trade CNST with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.34
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/04/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview

Details
  • Implied Volatility 0.00%
  • Historical Volatility 2.41%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.89
  • Number of Estimates 5
  • High Estimate -0.87
  • Low Estimate -0.91
  • Prior Year -0.70
  • Growth Rate Est. (year over year) -27.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.65 +1.01%
on 06/25/21
34.05 -0.18%
on 07/14/21
+0.29 (+0.86%)
since 06/14/21
3-Month
18.82 +80.61%
on 05/13/21
34.05 -0.18%
on 07/14/21
+10.91 (+47.27%)
since 04/14/21
52-Week
17.00 +99.94%
on 09/24/20
39.30 -13.51%
on 01/20/21
+5.43 (+19.01%)
since 07/14/20

Most Recent Stories

More News
MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology

Company Announces Successful Completion of Tender Offer Moves Forward with Strategic Funding Partnership with Royalty Pharma

MOR : 13.66 (-8.01%)
CNST : 33.99 (+0.06%)
Lifshitz Law Firm, P.C. Announces Investigation of ALTA, CAI, CNST, and IKNX

NEW YORK, NY / ACCESSWIRE / July 7, 2021 /

ALTA : 40.03 (-1.18%)
CAI : 55.83 (-0.14%)
CNST : 33.99 (+0.06%)
IKNX : 22.00 (-4.22%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates IKNX, MPB, JAX, CNST; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

IKNX : 22.00 (-4.22%)
MPB : 26.64 (-0.93%)
JAX : 13.86 (+0.65%)
CNST : 33.99 (+0.06%)
Lifshitz Law Firm, P.C. Announces Investigation of CNST, FFWM, SLCT, and GRA

NEW YORK, NY / ACCESSWIRE / July 2, 2021 / Lifshitz Law Firm, P.C.:

CNST : 33.99 (+0.06%)
FFWM : 22.42 (+1.31%)
SLCT : 15.45 (+0.98%)
GRA : 69.55 (-0.01%)
MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals

MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / July 1, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys") today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust...

MOR : 13.66 (-8.01%)
CNST : 33.99 (+0.06%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ICBK, CLDB, CAI, CNST; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / June 30, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

ICBK : 34.15 (+1.19%)
CLDB : 26.90 (+1.07%)
CAI : 55.83 (-0.14%)
CNST : 33.99 (+0.06%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds KNL, DTRC, SBBP, and CNST Shareholders About Its Ongoing Investigations

/PRNewswire/ --

KNL : 25.04 (+0.93%)
DTRC : 4.7500 (+0.74%)
SBBP : 2.49 (-0.80%)
CNST : 33.99 (+0.06%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, LDL, IKNX, CNST; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

RAVN : 58.41 (+0.02%)
LDL : 61.45 (+0.41%)
IKNX : 22.00 (-4.22%)
CNST : 33.99 (+0.06%)
Lifshitz Law Firm, P.C. Announces Investigation of CNST, FFWM, SLCT, and GRA

NEW YORK, NY / ACCESSWIRE / June 28, 2021 /

CNST : 33.99 (+0.06%)
FFWM : 22.42 (+1.31%)
SLCT : 15.45 (+0.98%)
GRA : 69.55 (-0.01%)
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates CORE, MMAC, CNST, SLCT; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / June 28, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CORE : 42.62 (-0.21%)
MMAC : 27.37 (+0.04%)
CNST : 33.99 (+0.06%)
SLCT : 15.45 (+0.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Constellation Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. It discovers and develops molecule therapeutics for the treatment of cancer, inflammatory and immunologic disorders. The company's lead product candidates consists of CPI-1205, which inhibits enhancer of zeste homolog 2 and...

See More

Key Turning Points

3rd Resistance Point 34.12
2nd Resistance Point 34.08
1st Resistance Point 34.04
Last Price 33.99
1st Support Level 33.96
2nd Support Level 33.92
3rd Support Level 33.88

See More

52-Week High 39.30
Last Price 33.99
Fibonacci 61.8% 30.78
Fibonacci 50% 28.15
Fibonacci 38.2% 25.52
52-Week Low 17.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar